Glucotrack (GCTK) Payables (2010 - 2025)

Glucotrack has disclosed Payables across 16 years of filings, most recently posting $4.5 million for Q4 2025.

• Quarterly Payables rose 351.25% year-over-year to $4.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.5 million (up 351.25% YoY) and the FY2025 annual result came in at $4.5 million, up 351.25% from the prior year.
• Payables retreated to $4.5 million in Q4 2025, from $4.7 million in the prior quarter.
• Over five years, Payables peaked at $4.7 million in Q3 2025 and troughed at $590000.0 in Q1 2022.
• A 5-year average of $1.4 million and a median of $835500.0 in 2023 frame the typical range for Payables.
• Annual changes were most pronounced in 2021 — Payables slumped 50.33% — and 2025, when it soared 351.25%.
• Tracing GCTK's Payables over 5 years: stood at $631000.0 in 2021, then climbed by 6.5% to $672000.0 in 2022, then increased by 24.85% to $839000.0 in 2023, then grew by 18.83% to $997000.0 in 2024, then surged by 351.25% to $4.5 million in 2025.
• Business Quant data shows GCTK's Payables at $4.5 million in Q4 2025, $4.7 million in Q3 2025, and $2.6 million in Q2 2025.